Successful treatment of pseudomyxoma peritonei with intraperitoneal 10 per cent dextrose, sizofiran and cisplatin.
Ohara
N
N
Department of Obstetrics and Gynecology, Kohnan Hospital, 5-16, 1-Chome, Kamokogahara, Higashinada-Ku, Kobe City, Hyogo Prefecture, 658-0064 Japan.
Teramoto
K
K
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002945:Cisplatin / Q000008:administration & dosage; D003520:Cyclophosphamide / Q000008:administration & dosage; D018282:Cystadenocarcinoma, Mucinous / Q000473:pathology*; D004317:Doxorubicin / Q000008:administration & dosage; D005260:Female; D005950:Glucose Solution, Hypertonic / Q000627:therapeutic use*; D006801:Humans; D007263:Infusions, Parenteral; D008875:Middle Aged; D010051:Ovarian Neoplasms / Q000473:pathology*; D010534:Peritoneal Neoplasms / Q000188:drug therapy* / Q000556:secondary; D011553:Pseudomyxoma Peritonei / Q000188:drug therapy* / Q000209:etiology; D012566:Sizofiran / Q000008:administration & dosage; D016896:Treatment Outcome
D005950:Glucose Solution, Hypertonic; D012566:Sizofiran; D004317:Doxorubicin; D003520:Cyclophosphamide; D002945:Cisplatin